You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-JAK-NVP-BSK805
NVP-BSK805

Chemical Structure : NVP-BSK805

CAS No.: 1092499-93-8

NVP-BSK805 (BSK 805;BSK-805;BSK805;NVP-BSK 805)

Catalog No.: PC-44039Not For Human Use, Lab Use Only.

NVP-BSK805 is a potent, selective and ATP-competitive inhibitor of JAK2 (V617F) and wt JAK2 (IC50=0.5 nM).

Packing Price Stock Quantity
10 mg $158 In stock
25 mg $258 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

NVP-BSK805 is a potent, selective and ATP-competitive inhibitor of JAK2 (V617F) and wt JAK2 (IC50=0.5 nM).
NVP-BSK805 displays >20-fold selectivity towards JAK1, JAK3, TYK2 and excellent selectivity in broader kinase profiling.
NVP-BSK805 blunts constitutive STAT5 phosphorylation in JAK2(V617F)-bearing cells.
NVP-BSK805 exhibits good oral bioavailability and a long half-life.

Physicochemical Properties

M.Wt 490.5476
Formula C27H28F2N6O
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Quinoxaline, 8-[3,5-difluoro-4-(4-morpholinylmethyl)phenyl]-2-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-

References

1. Baffert F, et al. Mol Cancer Ther. 2010 Jul;9(7):1945-55.

2. Pissot-Soldermann C, et al. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2609-13.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: